Case report: Dramatic recovery of lung adenocarcinoma-associated dermatomyositis with targeted lung cancer therapy alone

Oncologist

Volumn 13, Issue 1, 2008, Pages 79-81

  Zang, Yuan Sheng ^a   Xiu, Qing Yu ^a,c   Fang, Zheng ^a   Li, Bing ^a   Xia, Tian Bao ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b 306 HOSPITAL OF PLA   (China)

^c NONE   (China)

Author keywords

Corticosteroids; Dermatomyositis; Lung cancer; Targeted therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; GEFITINIB; PREDNISONE;

ADULT; ARTICLE; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DERMATOMYOSITIS; DRUG TARGETING; FEMALE; HUMAN; LUNG ADENOCARCINOMA; MUSCLE BIOPSY; MUSCLE WEAKNESS; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; RASH; SKIN BIOPSY; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; DERMATOMYOSITIS; FEMALE; GLUCOCORTICOIDS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; QUINAZOLINES; TREATMENT OUTCOME;

EID: 38849095896     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2007-0172     Document Type: Article

References (11)

1. Gabrilovich M, Raza M, Dolan S et al. Paraneoplastic polymyositis associated with squamous cell carcinoma of the lung. Chest 2006;129:1721-1723.
2. Mori H, Habe K, Hakamada A et al. Relapse of dermatomyositis after 10 years in remission following curative surgical treatment of lung cancer. J Dermatol 2005;32:290-294.
3. Callen JP, Wortmann RL. Dermatomyositis. Clin Dermatol 2006;24:363-373.
4. Tsang KW, Lam WK, Ip M. Response of dermatomyositis co-existing with non-small cell lung cancer to chemotherapy. Respir Med 1998;92:788-790.
5. Fujita J, Tokuda M, Bandoh S et al. Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature. Rheumatol Int 2001;20:81-84.
6. de Beukelaar JW, Sillevis Smitt PA. Managing paraneoplastic neurological disorders. The Oncologist 2006;11:292-305.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-347.
8. Weismann K. [Skin disorders as markers of internal disease. Paraneoplastic dermatoses.] Ugeskr Laeger 2000;162:6834-6839.
9. Schulman P, Kerr LD, Spiera H. A reexamination of the relationship between myositis and malignancy. J Rheumatol 1991;18:1689-1692.
10. Chung L, Genovese MC, Fiorentino DF. A pilot trial of rituximab in the treatment of patients with dermatomyositis. Arch Dermatol 2007;143:763-767.
11. Jordan JR, Paruthi S, Pichardo RO et al. Spontaneously remitting dermatomyositis. J Eur Acad Dermatol Venereol 2004;18:495-498.